Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06813_nanopub.RANPJ6cxlzrxGY__HvTtNJzMWqKEsIybHkhJjbKF1aZ1w#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB06813 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06813 label "Pralatrexate [drugbank:DB06813]" assertion.
- drugbank:DB06813 seeAlso DB06813 assertion.
- drugbank:DB06813 seeAlso pralatrexate.html assertion.
- drugbank:DB06813 seeAlso folotyn-drug.htm assertion.
- drugbank:DB06813 identifier "drugbank:DB06813" assertion.
- drugbank:DB06813 description "Pralatrexate is an antimetabolite for the treatment of relapsed or refractory peripheral T-cell lymphoma. It is more efficiently retained in cancer cells than methotrexate. FDA approved on September 24, 2009." assertion.
- drugbank:DB06813 title "Pralatrexate" assertion.
- drugbank:DB06813 bio2rdf_vocabulary:identifier "DB06813" assertion.
- drugbank:DB06813 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06813 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06813" assertion.
- drugbank:DB06813 bio2rdf_vocabulary:x-identifiers.org DB06813 assertion.
- drugbank:DB06813 drugbank_vocabulary:drugbank-id "DB06813" assertion.
- drugbank:DB06813 drugbank_vocabulary:x-cas cas:146464-95-1 assertion.
- drugbank:DB06813 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB06813 drugbank_vocabulary:x-atc atc:L01BA05 assertion.
- drugbank:DB06813 drugbank_vocabulary:x-chebi chebi:71223 assertion.
- drugbank:DB06813 drugbank_vocabulary:x-kegg kegg:D05589 assertion.
- drugbank:DB06813 drugbank_vocabulary:x-wikipedia wikipedia:Pralatrexate assertion.
- drugbank:DB06813 drugbank_vocabulary:x-ndc ndc:48818-001-01 assertion.